Memory CD4+ T cells that co-express PD1 and CTLA4 have reduced response to activating stimuli facilitating HIV latency
Authors:
- Rasmussen, Thomas A.
 - Zerbato, Jennifer M.
 - Rhodes, Ajantha
 - Tumpach, Carolin
 - Dantanarayana, Ashanti
 - McMahon, James H.
 - Lau, Jillian S.Y.
 - Chang, J. Judy
 - Gubser, Celine
 - Brown, Wendy
 - Hoh, Rebecca
 - Krone, Melissa
 - Pascoe, Rachel
 - Chiu, Chris Y.
 - Bramhall, Michael
 - Lee, Hyun Jae
 - Haque, Ashraful
 - Fromentin, Rèmi
 - Chomont, Nicolas
 - Milush, Jeffrey
 - Van der Sluis, Renee M.
 - Palmer, Sarah
 - Deeks, Steven G.
 - Cameron, Paul U.
 - Evans, Vanessa
 - Lewin, Sharon R.
 
Details:
Cell Reports Medicine, Volume 3, Issue 10, 2022-10-18
Article Link: Click here
Programmed cell death 1 (PD1) and cytotoxic T lymphocyte-associated protein 4 (CTLA4) suppress CD4+ T cell activation and may promote latent HIV infection. By performing leukapheresis (n = 21) and lymph node biopsies (n = 8) in people with HIV on antiretroviral therapy (ART) and sorting memory CD4+ T cells into subsets based on PD1/CTLA4 expression, we investigate the role of PD1 and CTLA 4 in HIV persistence. We show that double-positive (PD1+CTLA4+) cells in blood contain more HIV DNA compared with double-negative (PD1−CTLA4−) cells but still have a lower proportion of cells producing multiply spliced HIV RNA after stimulation as well as reduced upregulation of T cell activation and proliferation markers. Transcriptomics analyses identify differential expression of key genes regulating T cell activation and proliferation with MAF, KLRB1, and TIGIT being upregulated in double-positive compared with double-negative cells, whereas FOS is downregulated. We conclude that, in addition to being enriched for HIV DNA, double-positive cells are characterized by negative signaling and a reduced capacity to respond to stimulation, favoring HIV latency.

